Bridging Phase II and III Trials in Oncology
Bridging Phase II and III Trials in Oncology Strategies for Successfully Bridging Phase II and III Oncology Trials Introduction to Bridging Phase II and III Trials Bridging Phase II and III oncology trials is a strategic approach designed to accelerate drug development timelines while ensuring robust evidence generation. Traditionally, Phase II trials establish preliminary efficacy…